About admin

This author has not yet filled in any details.
So far admin has created 29 blog entries.

The Lancet – Les Tromperies de la Renommée

Dr. Ariel Beresniak, CEO and founder of Data Mining International reviews in this article in Causeur magazine, the highly controversial situation where the internationally reputed scientific journal The Lancet took its distance from the study it had previously published on the dangers of chloroquine.

Please click on the image for access to the full article:

2020-06-10T12:46:11+02:00June 6th, 2020|

Cost of human life during COVID pandemic

Dr. Ariel Beresniak presents an analysis behind economic decisions being made amidst Covid-19, in this article for Causeur Magazine in May 2020.

Please click on the image for access to the full article:

Le prix de la vie humaine - Causeur Mai 2020
2020-05-30T10:00:53+02:00May 18th, 2020|


Almost 60% of the world population is infected with the Helicobacter pylori bacteria: a new study establishes that a test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from this infection, thus contributing to prevent peptic ulcer and gastric cancer.

Helicobacter pylori infection is a major public health issue affecting 60% of the world’s population with 90% of Peptic Ulcer attributed to and 80% of Gastric Cancers associated with Hp infection.

With the support of an international expert panel composed of Pr Javier Gisbert & Dr Adrian Mc Nicholl (Spain), Pr Francesco Franceschi (Italy), Pr Peter Malfertheiner (Germany) and methodologists, a new study has been carried out to assess different strategies for Helicobacter pylori infection diagnosis & eradication control.

The results have been presented by Dr Adrian McNicholl (Hospital Universitario de La Princesa, Madrid, Spain) at the XXXIst International Workshop on Helicobacter & Microbiota in Inflammation and Cancer in Kaunas (Lithuania) on 14th September 2018 during a “State of the Art” session.

The study shows that a “Test & Treat strategy” including the use of Urea Breath Tests as recommended in Spain is as effective as carrying out an endoscopy alone and has shown to be cheaper and more cost-effective than the symptomatic treatment strategy to manage dyspeptic patients. This strategy also seems to be the most cost-effective to prevent gastric cancer.

Pr Javier Gisbert, (Hospital Universitario de La Princesa, Madrid, Spain) stated: “although this Test & treat” strategy is incorporated in guidelines in multiple countries, the analysis of the European Hp registry covering more than 20‘000 patients shows that it is not always implemented. We need to teach our colleagues to align clinical practice with guidelines and the results from this cost-effectiveness study is an excellent opportunity for this”

Jean-Nicolas Vernin, President of Mayoly Spindler declared: “as a key player in the field of Helicobacter pylori infection management, Mayoly Spindler is very proud to support this project with the aim to improve the diagnostic and the management of patients with Hp infection and help preventing Peptic Ulcer and Gastric Cancer across the world”.

By increasing awareness from Health Authorities, insurers, physicians, pharmacists and patients on the need for early diagnosis and eradication of Hp infection, this study will contribute to develop efficient prevention programs against Peptic Ulcer and Gastric Cancer.

2020-05-20T17:09:44+02:00November 27th, 2018|

DMI presents the QALYs’ inadequacies during the Ethics Prize Seminar in Stockholm

Dr Ariel Beresniak took part in the Ethics Prize Seminar in Stockholm in October 2016, where he discussed once again how inadequate, inaccurate and unethical the QALY approach is when used for making a decision about new medicines’ access to patients in need. 

This seminar was organised by the Swedish Council of Medical Ethics.

The full seminar broadcast can be viewed here. Dr Ariel Beresniak’s presentation starts at 1:50:13.

More information on the QALYs and DMI’s role in the ECHOUTCOME project: www.echoutcome.eu.

Back to News

2020-05-18T17:25:26+02:00December 19th, 2016|

New publication related to the EHR4CR project on the re-use of the electronic health data

The European research project Electronic Health Records for Clinical Research (EHR4CR) was co-funded by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Innovative Medicines Initiative. A new budgetary impact assessment published in the Journal of Health & Medical Informatics reveals that compared to current practices, the EHR4CR platform appears cost-saving for pharmaceutical industry, the primary sponsor of clinical trials.


The full article is available here.

More information on the EHR4CR project: www.ehr4cr.eu.

Back to News

2020-01-14T18:09:49+02:00August 9th, 2016|

Public Health promoted by Classical Music – a concert-conference hosted by DMI in the frame of the ASSET project

It is a well-known fact how music positively affects the intellectual development and improves the concentration. This relationship, appreciated by musicians and music fans is gradually gaining more attention also from the scientific research teams around the world. The scientific consortium ASSET, financed by the European Commission, proposes a unique way of integrating classical music in the promotion of public health by organising a piano concert where the classical piano pieces will be accompanied by the presentations of six international scientific experts.

“Concerto for Piano and Sciences” is the first event of this kind organised together with the Verbier Festival (Switzerland), one of the most esteemed classical music festivals in Europe. Andrey Gugnin, a Russian virtuoso pianist and laureate of several prestigious international piano competitions will include Verbier in his world tour and will perform on the Bösendorfer grand piano 12 Études opus 25 by Frédéric Chopin as well as the sublime but rarely heard Sonata Romantica by Nicolaï Medtner.

Dr Ariel Beresniak, the CEO of the research organisation Data Mining International and the host of this concert-conference said: « We have a great pleasure and honour to organise this event in partnership with the Verbier Festival, creating a unique opportunity for the public to attend to the combination of the virtuoso classical piano music and extremely informative public health interventions proposed by international experts. It’s not often that both the right and the left hemispheres of the human brain can be stimulated in this fashion at the same time in order to better understand the role and the impact of music on the education and the disease prevention. »

The topics presented by the public health experts during the concert-conference will touch more particularly on the aspects of individual and collective health (Dr Ariel Beresniak), the music’s impact on the brain (Dr Pierre Lemarquis), the cognitive effects of the early music education (Hélène Vareille), the human epidemics of animal origin (Dr Donato Greco), the epidemics response strategies (Dr Sylvie Briand) as well as various defence mechanisms that the communities can employ against future pandemics (Dr Alberto Perra).

Concerto for Piano and Sciences

Saturday 30 July 2016 at 16:00

Espace St Marc, Verbier/Le Châble, Canton du Valais, Switzerland

Reservation online for free entrance:


Press contacts and group reservations: concert@datamining-international.com

Back to News

2020-01-14T18:09:49+02:00July 13th, 2016|